Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Biomedical & Clinical Approaches to Improving Quality of Life

University of Alberta

$58,750.00

Predicting late effects of individual cancer survivors: A pilot methodological study

EF 2008-09

Résumé
The proposed research aims to enable physicians who provide follow-up care for cancer survivors to predict, with a clinically-appropriate degree of precision, the risk of long-term outcomes of cancer and its treatment more accurately, thereby assisting their work for improving survivors' quality of life. Assessing the risk of various late effects is a critical task for effective follow-up of cancer survivors. Appropriate screening and preventive strategies can be applied for "high-risk" survivors to reduce adverse outcomes of cancer and its treatment. The ability to accurately assess the risk of late effects also serves as the basis for developing and evaluating new intervention strategies. The proposed study investigates a completely new methodological framework that is expected to improve the assessment of various late effects risks among cancer survivors. Specifically, through the newly proposed framework, we will be able to accurately identify high-risk subgroups and precisely estimate their risk levels. This will enable: (a) survivors to avoid unnecessary anxieties and concerns if they are not at high risk; (b) survivors to avoid potential health risks associated with over-screening (e.g., medical exposures such as X-rays); (c) physicians to advise survivors with more appropriate follow-up plans; and (d) a more appropriate use of health-care resources.
Programme
Catalyst Grant: Biomedical & Clinical Approaches to Improving Quality of Life
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
182922
Name
Yasui Yutaka
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Catalyst Grant: Biomedical & Clinical Approaches to Improving Quality of Life
Projecttitle
Predicting late effects of individual cancer survivors: A pilot methodological study
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$58,750
Cihrequipment2
$0
Programname2
Catalyst Grant: Biomedical & Clinical Approaches to Improving Quality of Life
Keyworddelim
Childhood Cancer Survivor Study; Data Mining; High-Risk Groups; Individual Risk Prediction; Late Effects; Quality Of Life
Abstract
The proposed research aims to enable physicians who provide follow-up care for cancer survivors to predict, with a clinically-appropriate degree of precision, the risk of long-term outcomes of cancer and its treatment more accurately, thereby assisting their work for improving survivors' quality of life. Assessing the risk of various late effects is a critical task for effective follow-up of cancer survivors. Appropriate screening and preventive strategies can be applied for "high-risk" survivors to reduce adverse outcomes of cancer and its treatment. The ability to accurately assess the risk of late effects also serves as the basis for developing and evaluating new intervention strategies. The proposed study investigates a completely new methodological framework that is expected to improve the assessment of various late effects risks among cancer survivors. Specifically, through the newly proposed framework, we will be able to accurately identify high-risk subgroups and precisely estimate their risk levels. This will enable: (a) survivors to avoid unnecessary anxieties and concerns if they are not at high risk; (b) survivors to avoid potential health risks associated with over-screening (e.g., medical exposures such as X-rays); (c) physicians to advise survivors with more appropriate follow-up plans; and (d) a more appropriate use of health-care resources.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yasui, Yutaka
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Gender & Health~ $58,750~ $0~